Zobrazeno 1 - 10
of 444
pro vyhledávání: '"Ouranidis, A."'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract Vaccine manufacturing fosters the prevention, control, and eradication of infectious diseases. Recombinant DNA and in vitro (IVT) mRNA vaccine manufacturing technologies were enforced to combat the recent pandemic. Despite the impact of thes
Externí odkaz:
https://doaj.org/article/e3ee45ae36c14b1788951017251fd547
Autor:
Talimtzi, Persefoni, Ntolkeras, Antonios, Kostopoulos, Georgios, Bougioukas, Konstantinos I., Pagkalidou, Eirini, Ouranidis, Andreas, Pataka, Athanasia, Haidich, Anna-Bettina
Publikováno v:
In Journal of Clinical Epidemiology March 2024 167
Autor:
Petros N. Fountoulakis, Aikaterini Terzoudi, Dimitrios Tsiptsios, Andreas S. Triantafyllis, Anestis Matziridis, Eleni Leontidou, Apostolos Manolis, Konstantinos Tsamakis, Andreas Ouranidis, Paschalis Steiropoulos, Theofanis Vorvolakos, Aspasia Serdari, Gregory Tripsianis
Publikováno v:
Sleep Science, Vol 15, Iss 04, Pp 388-398 (2022)
Objective: To explore the association of sleep characteristics with cardiovascular disease (CVD) using self-reported questionnaires. Material and Methods: 957 adults between 19 and 86 years old were enrolled in this cross-sectional study. The partic
Externí odkaz:
https://doaj.org/article/1e0da0265f09427993168ce828cb4ccb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In European Journal of Pharmaceutical Sciences 1 November 2021 166
Autor:
Vasileios Vasilopoulos, Maria Pitou, Ilias Fekas, Rigini Papi, Andreas Ouranidis, Eleni Pavlidou, Panos Patsalas, Τheodora Choli-Papadopoulou
Publikováno v:
ACS Omega, Vol 5, Iss 41, Pp 26329-26334 (2020)
Externí odkaz:
https://doaj.org/article/b336d517a0b943278bb165dc8ebd19f8
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 2113 (2022)
Digital twins capacitate the industry 4.0 paradigm by predicting and optimizing the performance of physical assets of interest, mirroring a realistic in-silico representation of their functional behaviour. Although advanced digital twins set forth di
Externí odkaz:
https://doaj.org/article/218532a9aa044b7f8d973650c6522a3b
Autor:
Davidopoulou, Christina1,2 (AUTHOR), Ouranidis, Andreas1,2 (AUTHOR) ouranidis@auth.gr
Publikováno v:
Pharmaceutics. Oct2022, Vol. 14 Issue 10, pN.PAG-N.PAG. 16p.
Autor:
Nikolaos Pyrgidis, Ioannis Mykoniatis, Anna-Bettina Haidich, Maria Tirta, Persefoni Talimtzi, Dimitrios Kalyvianakis, Andreas Ouranidis, Dimitrios Hatzichristou
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Multiple systematic reviews explore the effect of phosphodiesterase type 5 (PDE5) inhibitors on erectile dysfunction (ED), with each study addressing specific outcomes. However, physicians and policymakers require a holistic approach of t
Externí odkaz:
https://doaj.org/article/03618577ed5c446a8f7f8e804673748c
Autor:
Ioannis Mykoniatis, Anna-Bettina Haidich, Nikolaos Pyrgidis, Maria Tirta, Persefoni Talimtzi, Dimitrios Kalyvianakis, Andreas Ouranidis, Dimitrios Hatzichristou
Publikováno v:
BMJ Open, Vol 11, Iss 8 (2021)
Introduction Phosphodiesterase-type 5 inhibitors (PDE5i) are the recommended first-line treatment for erectile dysfunction. Previous systematic reviews and meta-analyses suggest that they are a safe and effective option in many patient groups. Simila
Externí odkaz:
https://doaj.org/article/0e2eb91587b04bd59559a1cddee2b819